Expanded Cohort for Metastatic Colorectal Cancer (MCRC) Using Bevacizumab + Everolimus

Clinical trial NCT00597506 · COMPLETED

Trial details

NCT number: NCT00597506
Sponsor: Herbert Hurwitz
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Adenocarcinoma

Start date: 2007-10-01
Primary completion: 2010-06-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.